{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T11:01:41Z","timestamp":1779188501307,"version":"3.51.4"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.pnpbp.2015.01.009","type":"journal-article","created":{"date-parts":[[2015,1,17]],"date-time":"2015-01-17T07:00:43Z","timestamp":1421478043000},"page":"40-48","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Evaluation of the dopamine \u03b2-hydroxylase (D\u03b2H) inhibitor nepicastat in participants who meet criteria for cocaine use disorder"],"prefix":"10.1016","volume":"59","author":[{"suffix":"II","given":"Richard","family":"De La Garza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcy J.","family":"Bubar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Crystal L.","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. Gerard","family":"Moeller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas F.","family":"Newton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noelle C.","family":"Anastasio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tod A.","family":"Harper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David L.","family":"Ware","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaylyn J.","family":"Holstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason B.","family":"Jayroe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen I.","family":"Bandak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten Z.","family":"Reiman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann C.","family":"Neale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lesley B.","family":"Pickford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn A.","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2015.01.009_bb0005","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.drugalcdep.2006.08.016","article-title":"Disulfiram effects on responses to intravenous cocaine administration","volume":"87","author":"Baker","year":"2007","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pnpbp.2015.01.009_bb0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1600-0773.1993.tb01331.x","article-title":"Clinical pharmacology and toxicology of cocaine","volume":"72","author":"Benowitz","year":"1993","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.pnpbp.2015.01.009_bb0015","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s00213-005-0139-8","article-title":"Effects of dopamine beta-hydroxylase genotype and disulfiram inhibition on catecholamine homeostasis in mice","volume":"183","author":"Bourdelat-Parks","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2015.01.009_bb0030","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1360-0443.1998.9357137.x","article-title":"Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram","volume":"93","author":"Carroll","year":"1998","journal-title":"Addiction"},{"key":"10.1016\/j.pnpbp.2015.01.009_bb0025","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1046\/j.1360-0443.2000.95913355.x","article-title":"One-year follow-up of disulfiram and psychotherapy for cocaine-alcohol users: sustained effects of treatment","volume":"95","author":"Carroll","year":"2000","journal-title":"Addiction"},{"key":"10.1016\/j.pnpbp.2015.01.009_bb0020","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1001\/archpsyc.61.3.264","article-title":"Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trial","volume":"61","author":"Carroll","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.01.009_bb0035","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2165\/00002018-199920050-00003","article-title":"Safety issues concerning the use of disulfiram in treating alcohol dependence","volume":"20","author":"Chick","year":"1999","journal-title":"Drug Saf"},{"issue":"1\u20132","key":"10.1016\/j.pnpbp.2015.01.009_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2008.03.001","article-title":"The role of human drug self-administration procedures in the development of medications","volume":"96","author":"Comer","year":"2008","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pnpbp.2015.01.009_bb0045","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.drugalcdep.2013.02.036","article-title":"Crosswalk between DSM-IV dependence and DSM-5 substance use disorders for opioids, cannabis, cocaine and alcohol","volume":"132","author":"Compton","year":"2013","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.pnpbp.2015.01.009_bb0050","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/sj.mp.4000657","article-title":"A haplotype at the DBH locus, associated with low plasma dopamine beta-hydroxylase activity, also associates with cocaine-induced paranoia","volume":"5","author":"Cubells","year":"2000","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.01.009_bb0055","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.pnpbp.2013.11.013","article-title":"Assessment of safety, cardiovascular and subjective effects after intravenous cocaine and lofexidine","volume":"50","author":"De La Garza","year":"2014","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.01.009_bb0060","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/adb.12026","article-title":"The dopamine beta-hydroxylase inhibitor nepicastat increases dopamine release and potentiates psychostimulant-induced dopamine release in the prefrontal cortex","volume":"19","author":"Devoto","year":"2014","journal-title":"Addict Biol"},{"key":"10.1016\/j.pnpbp.2015.01.009_bb0065","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1124\/mi.9.4.6","article-title":"Mechanisms of disulfiram-induced cocaine abstinence: Antabuse and cocaine relapse","volume":"9","author":"Gaval-Cruz","year":"2009","journal-title":"Mol Interv"},{"issue":"11","key":"10.1016\/j.pnpbp.2015.01.009_bb0070","doi-asserted-by":"crossref","first-page":"e50583","DOI":"10.1371\/journal.pone.0050583","article-title":"Chronic inhibition of dopamine \u03b2-hydroxylase facilitates behavioral responses to cocaine in mice","volume":"7","author":"Gaval-Cruz","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2015.01.009_bb0075","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0006-3223(99)00310-8","article-title":"Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: a preliminary trial","volume":"47","author":"George","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.01.009_bb0080","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/0024-3205(64)90031-1","article-title":"Inhibition of dopamine-beta-hydroxylase by disulfiram","volume":"3","author":"Goldstein","year":"1964","journal-title":"Life Sci"},{"key":"10.1016\/j.pnpbp.2015.01.009_bb0095","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s11920-013-0415-y","article-title":"Pharmacotherapy for stimulant-related disorders","volume":"15","author":"Haile","year":"2013","journal-title":"Curr Psychiatry Rep"},{"issue":"9","key":"10.1016\/j.pnpbp.2015.01.009_bb0090","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0006-3223(03)00241-5","article-title":"Disulfiram facilitates the development and expression of locomotor sensitization to cocaine in rats","volume":"54","author":"Haile","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.01.009_bb0085","doi-asserted-by":"crossref","first-page":"e47702","DOI":"10.1371\/journal.pone.0047702","article-title":"The impact of disulfiram treatment on the reinforcing effects of cocaine: a randomized clinical trial","volume":"7","author":"Haile","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2015.01.009_bb0100","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.pharmthera.2012.01.010","article-title":"Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate","volume":"134","author":"Haile","year":"2012","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pnpbp.2015.01.009_bb0105","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3109\/03602537908993897","article-title":"Disulfiram (tetraethylthioperoxydicarbonic diamide): a reappraisal of its toxicity and therapeutic application","volume":"9","author":"Haley","year":"1979","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.pnpbp.2015.01.009_bb0110","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/0006-3223(94)00361-6","article-title":"Behavioral, physiological, and pharmacological interaction of cocaine and disulfiram in humans","volume":"37","author":"Hameedi","year":"1995","journal-title":"Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2015.01.009_bb0115","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00213-008-1079-x","article-title":"Controversies in translational research: drug self-administration","volume":"199","author":"Haney","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2015.01.009_bb0120","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2174\/138161280406221011113124","article-title":"Dopamine-beta-hydroxylase inhibition: a novel sympatho-modulatory approach for the treatment of congestive heart failure","volume":"4","author":"Hegde","year":"1998","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.pnpbp.2015.01.009_bb0125","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1176\/ajp.150.4.675b","article-title":"Disulfiram therapy in patients abusing cocaine and alcohol","volume":"150","author":"Higgins","year":"1993","journal-title":"Am J Psychiatry"},{"issue":"11","key":"10.1016\/j.pnpbp.2015.01.009_bb0130","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.biopsych.2006.08.012","article-title":"Dopamine beta-hydroxylase gene (DbetaH) -1021C-->T influences self-reported paranoia during cocaine self-administration","volume":"61","author":"Kalayasiri","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.01.009_bb0135","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0031-6997(25)07036-X","article-title":"Dopamine-beta-hydroxylase","volume":"17","author":"Kaufman","year":"1965","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pnpbp.2015.01.009_bb0140","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.biopsych.2012.07.011","article-title":"Pharmacogenetic randomized trial for cocaine abuse: disulfiram and dopamine beta-hydroxylase","volume":"73","author":"Kosten","year":"2013","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.01.009_bb0145","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0009-2797(00)00224-6","article-title":"Overview\u2014in vitro inhibition of aldehyde dehydrogenase by disulfiram and metabolites","volume":"130\u2013132","author":"Lipsky","year":"2001","journal-title":"Chem Biol Interact"},{"issue":"3","key":"10.1016\/j.pnpbp.2015.01.009_bb9000","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s00213-006-0323-5","article-title":"Paradigm to investigate the regulation of cocaine self\u2212administration in human cocaine users: a randomized trial","volume":"185","author":"Lynch","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2015.01.009_bb0150","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1124\/jpet.113.207746","article-title":"Dopamine beta-hydroxylase inhibitors enhance the discriminative stimulus effects of cocaine in rats","volume":"347","author":"Manvich","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2015.01.009_bb0155","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0006-3223(97)00506-4","article-title":"Chronic disulfiram treatment effects on intranasal cocaine administration: initial results","volume":"43","author":"McCance-Katz","year":"1998","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.01.009_bb0160","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0376-8716(98)00050-7","article-title":"Disulfiram effects on acute cocaine administration","volume":"52","author":"McCance-Katz","year":"1998","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pnpbp.2015.01.009_bb0165","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s11920-008-0062-x","article-title":"Use of stimulants to treat cocaine and methamphetamine abuse","volume":"10","author":"Moeller","year":"2008","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.pnpbp.2015.01.009_bb0170","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0022-3565(25)27291-3","article-title":"Inhibition of dopamine-beta-hydroxylase by disulfiram in vivo","volume":"152","author":"Musacchio","year":"1966","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.pnpbp.2015.01.009_bb0175","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/JCP.0b013e3181934451","article-title":"Pronounced paranoia as a result of cocaine-disulfiram interaction: case report and mode of action","volume":"29","author":"Mutschler","year":"2009","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2015.01.009_bb0185","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.pbb.2005.07.012","article-title":"Cocaine and methamphetamine produce different patterns of subjective and cardiovascular effects","volume":"82","author":"Newton","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pnpbp.2015.01.009_bb0180","doi-asserted-by":"crossref","first-page":"e30854","DOI":"10.1371\/journal.pone.0030854","article-title":"Noradrenergic alpha(1) receptor antagonist treatment attenuates positive subjective effects of cocaine in humans: a randomized trial","volume":"7","author":"Newton","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2015.01.009_bb0190","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1046\/j.1360-0443.2000.9522198.x","article-title":"Disulfiram treatment for cocaine dependence in methadone-maintained opioid addicts","volume":"95","author":"Petrakis","year":"2000","journal-title":"Addiction"},{"key":"10.1016\/j.pnpbp.2015.01.009_bb0195","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.drugalcdep.2011.05.015","article-title":"A double-blind, placebo-controlled assessment of the safety of potential interactions between intravenous cocaine, ethanol, and oral disulfiram","volume":"119","author":"Roache","year":"2011","journal-title":"Drug Alcohol Depend"},{"issue":"10","key":"10.1016\/j.pnpbp.2015.01.009_bb0200","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1038\/sj.npp.1301000","article-title":"Dopamine beta-hydroxylase knockout mice have alterations in dopamine signaling and are hypersensitive to cocaine","volume":"31","author":"Schank","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2015.01.009_bb0205","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.drugalcdep.2013.12.007","article-title":"Randomized clinical trial of disulfiram for cocaine dependence or abuse during buprenorphine treatment","volume":"136","author":"Schottenfeld","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pnpbp.2015.01.009_bb0215","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1038\/npp.2010.127","article-title":"Disulfiram attenuates drug-primed reinstatement of cocaine seeking via inhibition of dopamine beta-hydroxylase","volume":"35","author":"Schroeder","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2015.01.009_bb0210","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/npp.2012.267","article-title":"The selective dopamine beta-hydroxylase inhibitor nepicastat attenuates multiple aspects of cocaine-seeking behavior","volume":"38","author":"Schroeder","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"Suppl. 20","key":"10.1016\/j.pnpbp.2015.01.009_bb0220","first-page":"22","article-title":"The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-iv and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.01.009_bb0225","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.drugalcdep.2012.11.021","article-title":"The alpha-1 adrenergic antagonist doxazosin for treatment of cocaine dependence: a pilot study","volume":"131","author":"Shorter","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pnpbp.2015.01.009_bb0230","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1369-1600.2008.00138.x","article-title":"Norepinephrine and stimulant addiction","volume":"14","author":"Sofuoglu","year":"2009","journal-title":"Addict Biol"},{"key":"10.1016\/j.pnpbp.2015.01.009_bb0235","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1038\/sj.bjp.0701315","article-title":"Catecholamine modulatory effects of nepicastat (rs-25560-197), a novel, potent and selective inhibitor of dopamine-beta-hydroxylase","volume":"121","author":"Stanley","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pnpbp.2015.01.009_bb0240","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1207\/s15327590ijhc1002_3","article-title":"After effects and sense of presence in virtual environments: formulation of a research and development agenda","volume":"10","author":"Stanney","year":"1998","journal-title":"Int J Hum Comput Interact"},{"issue":"3","key":"10.1016\/j.pnpbp.2015.01.009_bb9005","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s00213-005-2192-8","article-title":"A paradigm to investigate the self\u2212regulation of cocaine administration in humans","volume":"180","author":"Sughondhabirom","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2015.01.009_bb0245","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.drugalcdep.2014.05.008","article-title":"Treatment with modafinil and escitalopram, alone and in combination, on cocaine-induced effects: a randomized, double blind, placebo-controlled human laboratory study","volume":"141","author":"Verrico","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pnpbp.2015.01.009_bb0250","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.yco.0000165596.98552.02","article-title":"Pharmacotherapy and other treatments for cocaine abuse and dependence","volume":"18","author":"Vocci","year":"2005","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/j.pnpbp.2015.01.009_bb0255","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1530-0277.1993.tb00745.x","article-title":"Screening for disulfiram-induced liver test dysfunction in an inpatient alcoholism program","volume":"17","author":"Wright","year":"1993","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.pnpbp.2015.01.009_bb0260","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1086\/318198","article-title":"A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: evidence for a major functional polymorphism at the DBH locus","volume":"68","author":"Zabetian","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pnpbp.2015.01.009_bb0265","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.biopsych.2005.02.003","article-title":"Prazosin, an alpha-1 adrenergic antagonist, reduces cocaine-induced reinstatement of drug-seeking","volume":"57","author":"Zhang","year":"2005","journal-title":"Biol Psychiatry"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027858461500010X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027858461500010X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T00:45:24Z","timestamp":1747442724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027858461500010X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":55,"alternative-id":["S027858461500010X"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2015.01.009","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the dopamine \u03b2-hydroxylase (D\u03b2H) inhibitor nepicastat in participants who meet criteria for cocaine use disorder","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2015.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}